No headlines found.
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
Globe Newswire (Fri, 10-Jul 6:30 AM ET)
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
Basel Medical Group - trades on the NASDAQ stock market under the symbol BMGL.
As of September 18, 2026, BMGL stock price climbed to $4.61 with 28,193 million shares trading.
BMGL has a beta of 1.18, meaning it tends to be more sensitive to market movements. BMGL has a correlation of 0.03 to the broad based SPY ETF.
BMGL has a market cap of $7.29 million. This is considered a Sub-Micro Cap stock.
BMGL has underperformed the market in the last year with a return of -79.2%, while the SPY ETF gained +16.8%. In the last 3 month period, BMGL fell short of the market, returning -37.7%, while SPY returned +2.3%. However, in the most recent 2 weeks BMGL has outperformed the stock market by returning +0.7%, while SPY returned -0.9%.
BMGL support price is $3.75 and resistance is $4.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMGL shares will trade within this expected range on the day.
